NCT00698230 - Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics | Biotech Hunter

Enrollment

302

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions

Type 2 Diabetes

Interventions

DRUG

INCB013739

INCB013739 5 mg QD tablet

DRUG

INCB013739

INCB013739 15 mg QD tablet

DRUG

INCB013739

INCB013739 50 mg QD tablet

DRUG

INCB013739

INCB013739 100 mg QD tablet

DRUG

INCB013739

INCB013739 200 mg QD

DRUG

Placebo comparator matching INCB013739

Orally once daily tablet

DRUG

Metformin

Trial Locations (68)

10016

New York

11413

Springfield Gardens

14224

West Seneca

16601

Altoona

18960

Sellersville

19046

Jenkintown

19438

Harleysville

21045

Columbia

22015

Burke

23666

Hampton

27103

Winston-Salem

28117

Mooresville

28562

New Bern

29303

Spartanburg

29582

North Myrtle Beach

29615

Greenville

30165

Rome

30338

Dunwoody

32626

Chiefland

32779

Longwood

32806

Orlando

33021

Hollywood

33126

Miami

33140

Miami Beach

33143

South Miami

33614

Tampa

34471

Ocala

35242

Birmingham

37620

Bristol

44614

Norton

45429

Kettering

48314

Sterling Heights

53209

Milwaukee

62220

Belleville

63031

Florissant

63128

St Louis

63141

St Louis

66216

Shawnee Mission

73071

Norman

75230

Dallas

76180

North Richland Hills

76502

Temple

76710

Waco

77004

Houston

77023

Houston

77074

Houston

77081

Houston

77090

Houston

78229

San Antonio

78705

Austin

79705

Midland

80909

Colorado Springs

89101

Las Vegas

90057

Los Angeles

91307

Calabasas

93720

Fresno

95032

Los Gatos

Calabash

Unknown

Artesia

Santa Ana

Georgetown

04401

Bangor

00983

Carolina

00738

Fajardo

00716

Ponce

00745

Río Grande

00909-1711

San Juan

00926-2832

San Juan